Doximity delivered double-digit revenue growth in fiscal Q3 2026, generating strong net income and adjusted EBITDA margins while continuing to produce robust cash flow.

Doximity delivered a robust fiscal second quarter for 2026, with total revenues reaching $168.5 million, marking a 23% increase year-over-year. The company also saw substantial growth in net income, non-GAAP net income, and adjusted EBITDA, alongside strong operating and free cash flow generation. The platform's growth was attributed to new AI tools and increased prescriber engagement.

Doximity delivered a robust performance in Q1 Fiscal 2026, exceeding expectations with a 15% increase in total revenues to $145.9 million. The company demonstrated strong profitability, with net income rising to $53.3 million and non-GAAP net income reaching $71.9 million. Operating cash flow and free cash flow also saw substantial growth, increasing by 51% and 52% respectively, highlighting efficient operations and strong cash generation.

Doximity reported strong financial results for the fourth quarter and fiscal year 2025, with significant year-over-year increases in revenue, net income, and cash flows. The company highlighted record engagement and the positive impact of its tools on medical professionals.

Doximity reported strong fiscal Q3 2025 results with revenue of $168.6 million, up 25% YoY. Net income surged 57% to $75.2 million, and adjusted EBITDA increased 39% to $102.0 million, reflecting solid profitability and operational efficiency.

Doximity reported a 20% year-over-year increase in total revenue, reaching $136.8 million. Net income grew by 44% year-over-year. The company provided guidance for the next quarter and updated its full-year outlook.

Doximity announced its Q4 2023 financial results, featuring an 18% year-over-year increase in revenue to $111.0 million and a net income of $30.7 million, representing a 28% margin. The company also appointed Craig Overpeck as SVP of commercial operations and Ben Greenberg as SVP of commercial products.

Doximity reported total revenues of $115.3 million, an 18% increase year-over-year. Operating cash flow was $48.7 million, up 78% year-over-year, and free cash flow was $47.5 million, up 85% year-over-year.

Doximity reported a strong fiscal Q2 2023, with revenue reaching $102.2 million, a 29% increase year-over-year. The company's telehealth platform saw record usage, and Doximity is investing in tools to help physicians save time and improve patient care.

Doximity reported a strong first quarter for fiscal year 2023, with revenue reaching $90.6 million, a 25% increase year-over-year. The company's operating cash flow and free cash flow also saw significant growth, increasing by 35% and 32% respectively.

Doximity reported a strong first quarter for fiscal year 2022, with revenue up 100% year-over-year and net income margin of 36%. The company's adjusted EBITDA margin was 43%.